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1. Introduction 
The antiketogenic action of propionate and its in- 
hibitory effect on fatty acid and acetate oxidation has 
been known for many years [l-3]. However, discor- 
dant interpretations have been proposed concerning 
the mechanism of this action [l-3] . The results re- 
ported in the present paper strongly suggest hat the 
antiketogenic action of propionate can be attributed 
predominantly to an inhibition of fatty acid activation 
while that of succinate to an improved incorporation 
of acetylCoA into citrate. 
2. Materials and methods 
Mitochondria were prepared from liver of Wistar 
strain albino rats according to the procedure of 
Schneider and Hogeboom in 0.25 M sucrose [4]. In- 
cubation was carried out in Barcroft vessels at 25”. 
14C activity was determined by liquid scintillation 
counting. Acetoacetate was measured enzymatically 
according to Williamson et al. [S] . 
The concentrations of ATP, ADP and AMP in 
mitochondria were measured enzymatically as pre- 
viously described [6] . 
Uniformly labelled “C-oleate was obtained from 
Radiochemical Centre, Amersham. 
Reagents were analytical grade, L-propionylcarni- 
tine and L-palmitoylcarnitine were kindly supplied by 
Italseber Farmaceutici (Milano, Italy). 
3. Results 
The results reported in table 1 show that propion- 
ate strongly inhibited oleate oxidation by rat liver 
mitochondria, as can be deduced from the sharp de- 
crease in metabolites produced by oxidation and 
represented by the sum of 14C-labelled soluble meta- 
bolites plus 14C02. Propionylcarnitine, on the con- 
trary, increased 14C-oleate oxidation. Since carnitine 
also evoked a similar stimulation, the propionylcar- 
nitine effect seems to be due mainly to the release of 
free carnitine during its conversion into propionylCoA 
[71 . 
A study of mitochondrial endogenous adenine 
nucleotides indicated that propionate, unlike suc- 
cinate and propionylcarnitine, induced a remarkable 
decrease of ATP/AMP ratio. This decrease, as was 
previously reported [8] , is a very unfavourable con- 
dition for the activity of ATP dependent acylCoA 
synthetase (Acid:CoA ligase AMP) which is sensitive 
to AMP [8]. 
From the results reported in table 2 it can be ob- 
served that propionate, as well as succinate, inhibited 
the formation of acetoacetate by rat liver mitochon- 
dria incubated in the presence of oleate. Propionyl- 
carnitine, on the contrary, did not decrease, but 
rather increased acetoacetate formation. Furthermore, 
the results of table 2 show that the inhibition of ace- 
toacetate formation by succinate was completely 
abolished by the addition of malonate, which, how- 
ever, did not remove the inhibition produced by 
propionate. 
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Table 1 
Action of propionate and succinate on oleate utilization in rat liver mitochondria. 
Additions CZZrn per mg per 5 min 
CO2 + acid soluble activity 
(nmoles/mg Prot) 
ATP ADP AMP 
1. Oleate 4,600 4.3 5.5 1.1 
2. Oleate + 5 mM propionate 990 1.4 5.1 4.1 
3. Oleate + 5 mM succinate 4,800 5.5 4.2 1.5 
4. Oleate + 5 mM propionylcn 8,900 5.3 6.2 1.5 
5. Oleate + 5 mM carnitine 8,550 7.0 2.3 1.5 
The incubation mixture contained in a final volume of 1 ml: 15 mM phosphate buffer pH 7.4,20 mM NaCl, 50 mM KCl, 5 mM 
MgCla, 25 mM sucrose, O.l.mM 14C-oleate (U) (2.1 X lo6 cpm/@mole), 8 mg mitochondrial protein. 14C02 was trapped by 0.2 
ml of 1 M hyamine hydroxide. After 5 min of incubation the reaction was stopped by the addition of 0.2 ml of 2% HaS.04 
(v/v). The shaking was continued for an additional 15 min. After the addition of 0.1 ml of cont. HCIO,, both hyamine 14C02 
and the HC104-soluble activity were determined by liquid-scintillation’counting. The acid-soluble activity represents the metabol- 
ites derived from the acid-insoluble oleate. Temperature 25”. Time 5 min. 
Moreover, when pahnitoylcarnitine, whose oxida- 
tion does not require a preliminary activation, was sub- 
stituted for oleate, succinate, unlike propionate, sub- 
stantially inhibited acetoacetate formation. Here 
again malonate abolished such an inhibition. 
4. Discussion 
For a better understanding of the results reported 
here, it is worthwhile mentioning that propionate is 
activated inside the inner membrane at the expense 
of endogenous ATP [9, lo] . Also, oleate under the 
conditions reported here is activated in the same space 
and by the same mechanism [ 1 I] . 
In the light of these circumstances it is clear why 
a high AMP level builds up within the mitochondria 
when oleate and propionate are both present in the 
incubation medium (see table 2). 
It has been previously reported that intramitochon- 
drially formed AMP inhibits the ATP dependent 
thiokinase (Acid:CoA ligase AMP 6.2.1.3) [8]. Con- 
sequently, it seems reasonable that the observed in- 
hibition of oleate oxidation induced by propionate 
(as can be deduced from the sharp decrease in 14C02 
and acid soluble activity deriving from r4C-oleate) 
can be attributed to a high level of AMP in the pres- 
ence of oleate plus propionate. 
That the antiketogenic action of propionate is due 
to an inhibition of fatty acid oxidation is also demon- 
Table 2 
Action of propionate and succinate on acetoacetate formation from oleate 
and palmitoylcarnitine in the presence and in the absence of malonate. 
Additions Acetoacetate (nmoles/mg prot/min) 
_ + 10 mM malonate 
0.1 mM oleate 1.60 2.20 
+ 5 mM propionate 0.50 0.80 
+ 5 mM succinate 0.10 2.00 
+ 5 mM propionylcarnitine 3.00 2.30 
0.1 mM Palmitoylcarnitine 2.10 2.30 
+ 5 mM propionate 1.60 2.10 
+ 5 mM succinate 0.20 2.00 
+ 5 mM propionylcarnitine 2.90 2.00 
Time, temperature and incubation medium, without 14C-oleate (U), as in table 1. 
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strated by the observation that propionylcarnitine, 
an already “activated” substrate, does not modify 
intramitochondrial ATP/AMP ratio and does not in- 
hibit either fatty acid oxidation or acetoacetate for- 
mation. Furthermore, the failure of propionate to 
inhibit acetoacetate formation when oleate is replaced 
by palmitoylcarnitine is additional evidence for the 
proposed mechanism. 
In the case of succinate an increased oxaloacetate 
formation seems to be the main factor involved in the 
inhibition of acetoacetate formation [ 121 . 
Oxaloacetate favours the incorporation of acetyl- 
CoA into citrate, thus decreasing its condensation into 
acetoacetate. In fact, the effect of succinate, unlike 
that of propionate, is completely abolished by malon- 
ate. 
All these observations make reasonable the conclu- 
sion that the antiketogenic action of propionate is 
predominantly a consequence of an inhibition of fat- 
ty acid oxidation, while that of succinate seems en- 
tirely attributable to an enhancement of acetylCoA 
utilization for the citrate synthesis. 
References 
[l] K. Lang and K.M. Bassler, Klin. Wochenschrift 31 
(1953) 675. 
[2] E.J. Masoro, J.M. Felts,S.S. PanagosandD. Rapport, 
Arch. Biochem. Biophys. 68 (1957) 270. 
[3] R.J. Pennington and J.M. Appleton, Biochem. J. 69 
(1958) 119. 
[4] W.C. Schneider and G.H. Hogeboom J..Biol. Chem. 183 
(1950) 123. 
, ]5] D.H. Williamson, J. Mellanby and H.A. Krebs, Biochem. 
J. 82 (1962) 90. 
[6] Z. Drahota, A. Alexandre, C.R. Rossi and N. Siliprandi, 
Biochim. Biophys. Acta 205 (1970) 491. 
[7] LB. Fritz, in: Cellular Compartmentation and Control of 
Fatty Acid Metabolism, ed. J. Bremer (Academic Press, 
London, 1968) p. 39. 
[8] S.V. Pande and J.F. Mead, J. Biol. Chem. 243 (1968) 
352. 
[9] H.R. Scholte, E.M. Wit-Peeters and J.C. Bakker, Biochim. 
Biophys. Acta 231 (1971) 479. 
[lo] C. Barth, M. Sladek and K. Decker, Biochim. Biophys. 
Acta 260 (1972) 1. 
[ 111 C.R. Rossi, L. Galzigna, A. Alexandre and D.M. Gibson, 
J. Biol. Chem. 242 (1967) 2102. 
[ 121 J. Bremer, Biochim. Biophys. Acta 116 (1966) 1. 
10 
